Specialty & Generic Drug Manufacturers
DeltaScreener covers 63 Specialty & Generic Drug Manufacturers companies listed on the NYSE, NASDAQ and AMEX. The table below shows the 63 largest by market capitalisation; every figure on this page is a median across those 63, not an average, because a handful of loss-making micro-caps would otherwise distort it.
Across the largest Specialty & Generic Drug Manufacturers companies, the median price-to-earnings ratio is 0.0, median return on equity is -8.0%, the median net margin is -4.0%, 9 of the 63 largest pay a dividend.
Largest Specialty & Generic Drug Manufacturers companies
Highest dividend yield in Specialty & Generic Drug Manufacturers
Lowest P/E in Specialty & Generic Drug Manufacturers
Companies reporting a loss are excluded, since a negative P/E is not a valuation measure.
Other industries in Healthcare
All sectors
Specialty & Generic Drug Manufacturers stocks — frequently asked questions
How many Specialty & Generic Drug Manufacturers stocks are there?
DeltaScreener covers 63 Specialty & Generic Drug Manufacturers companies on the NYSE, NASDAQ and AMEX.
What is the largest Specialty & Generic Drug Manufacturers company?
Teva Pharmaceutical Industries Limited (TEVA) is the largest Specialty & Generic Drug Manufacturers company by market capitalisation, at $46.54B.
What is a typical P/E ratio for Specialty & Generic Drug Manufacturers stocks?
Across the 63 largest Specialty & Generic Drug Manufacturers companies the median price-to-earnings ratio is 0.0. Individual companies vary widely, and loss-making companies have no meaningful P/E at all.
Which Specialty & Generic Drug Manufacturers stock has the highest dividend yield?
Indivior Pharmaceuticals, Inc. (INDV) has the highest dividend yield among Specialty & Generic Drug Manufacturers stocks at 23.37%. A high yield can reflect a falling share price as much as a generous dividend.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.